Why the study?
Do different commercial APTT reagents yield comparable results when monitoring heparin therapy?
Do different commercial APTT reagents yield comparable results when monitoring heparin therapy?
Different commercial APTT reagents yield considerably varying results for heparin monitoring, indicating that reagent systems cannot be used interchangeably without standardization.
No takes yet. Share an insight, caveat, or question.
APTT reagent variability in animal heparin models cautions against interchangeable use; leaves open human standardization studies.
Soloway et al. (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: